Matthew Sperrin

Jun 17, 2024 | medrxiv.org | Matthew Sperrin |Pieta Schofield |Iain Buchan

I have read the journal's policy and the authors of this manuscript have the following competing interests: A.G.M. declares i) a UCB Pharma grant paid to University of Liverpool for the National Audit of Seizure Management in Hospitals (NASH) study, which is unrelated to the submitted work ii) an Angelini grant to be paid to University of Liverpool as co-applicant for A multi-method PRoject to maximise efficient and equitable pathways tO suPport from a rEgional epiLepsy centre (PROPEL), which...